CFDB - Cystic Fibrosis DataBase

All subcategories » trial from www.clinicaltrials.gov

Evaluation of Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis Subjects Without an F508del Mutation - Phase 3 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2022
  • Vertex Pharmaceuticals Incorporated

Efficacy of Intensive Cholecalciferol Monitoring and Supplementation on Serum vitD Levels in Pediatric Patients With CF - Phase 4 - Recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2022
  • Hospital Infantil de Mexico Federico Gomez

CYstic Fibrosis bacterioPHage Study at Yale (CYPHY) - Phase 1|Phase 2 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2021
  • Yale University

A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection - Phase 2|Phase 3 - Recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2021
  • Bambino Gesù Hospital and Research Institute|University of Exeter|Radboud University|Consorzio per Valutazioni Biologiche e Farmacologiche

Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection - Phase 1|Phase 2 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2021
  • BiomX, Inc.

A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF) - Phase 3 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2021
  • Vertex Pharmaceuticals Incorporated

Study to Evaluate Adverse Events and Change in Disease Activity With Oral Capsules of Galicaftor/Navocaftor/ABBV-119 Combination Therapy in Adult Participants With Cystic Fibrosis - Phase 2 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2021
  • AbbVie

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance - Phase 2 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2021
  • University of Pennsylvania|Children's Hospital of Philadelphia

Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis - Phase 1|Phase 2 - Recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2020
  • Armata Pharmaceuticals, Inc.|Cystic Fibrosis Foundation

Effect of Postprandial Insulin Administration of Faster-acting Insulin Analogue Versus Pre-prandial Administration of Acting-insulin Analogue in Cystic Fibrosis Related Diabetes - Phase 4 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2020
  • University Hospital, Strasbourg, France